Efficacy of Asacol

Mucosal Healing

Asacol Delivers Rapid Mucosal Healing—in as Few as 3 Weeks

According to ACG Guidelines, reducing mucosal inflammation is an important goal of ulcerative colitis therapy.1

Mucosal Healing at 3 and 6 Weeks
  • Mucosal healing defined as an endoscopy subscore of 0 or 1
  • Analysis includes patients with an endoscopy subscore ≥2 at baseline

References: 1. Kornbluth A et al. Am J Gastroenterol. 2004;99:1371-1385. 2. Sninsky CA et al. Gastroenterology & Hepatology. 2008;4(suppl 4):1-10.

Asacol Delivers Rapid Mucosal Healing—in All Extents of Ulcerative Colitis

Efficacy throughout the colon is important when choosing an ulcerative colitis therapy.

Mucosal Healing at 3 and 6 Weeks
  • Mucosal healing defined as an endoscopy subscore of 0 or 1
  • Analysis includes patients with an endoscopy subscore ≥2 at baseline

References: 1. Sninsky CA et al. Gastroenterology & Hepatology. 2008;4(suppl 4):1-10.

Asacol (mesalamine) delayed-release tablets, available only by prescription, are indicated to treat mild to moderate flare-ups of ulcerative colitis and maintain remission of ulcerative colitis. Asacol is generally well-tolerated. In studies of flare-ups, some people taking Asacol reported headache, abdominal pain, general pain, rash, upset stomach, and worsening of colitis symptoms. In a six-month maintenance study, some people reported headache, runny nose, general pain, sore throat, infection, and nervousness. You should not take Asacol if you are allergic to Asacol or to salicylates such as aspirin. Tell your doctor if you have kidney problems or a history of kidney disease. It is recommended that all people have their kidney function tested prior to starting Asacol tablets and periodically while on Asacol therapy. Serious side effects may occur. If you have questions about taking Asacol, please talk to your doctor.
Adjust Font SizeSmall TextMedium TextLarge Text

This information was printed from Asacol.com.
Visit Asacol.com to get more information on Ulcerative Colitis.
Asacol is a registered trademark of Medeva Pharma Suisse AG, used under license by Procter & Gamble Pharmaceuticals, Inc.

Privacy BBB OnLine